• About
  • Masthead
  • License Content
  • Advertise
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Right ventricular structure associated with an increased risk of heart failure and cardiovascular death; (MESA) Right ventricle study

bys25qthea
October 3, 2012
in Cardiology, Chronic Disease
Reading Time: 3 mins read
Share on FacebookShare on TwitterShare on LinkedIn

Image: PD

Key study points:

1. The presence of right ventricular (RV) hypertrophy, as measured by cardiac MRI, in individuals without cardiovascular disease at baseline, was correlated with an increased risk of heart failure or death due to cardiovascular causes.

 2. This association held even after taking into account left ventricular (LV) hypertrophy.

Primer: It is a truth universally acknowledged that a conversation about cardiovascular risk must include a nod to the left ventricle (LV), whose distress might manifest as chest pain in a patient with LV ischemia, or as increased ECG voltage in a patient with hypertension.  In comparison, the contributions of RV structure and function to cardiovascular disease are not yet well understood. RV morphology was, in fact, dismissed as unimportant in historical animal studies of cardiac function.  However, recent studies of patients with pulmonary hypertension and congestive heart failure have marked RV size and ejection fraction as independent predictors of survival.  Yet, the elucidation of the role of the RV in the community-based patient has proved elusive.

 Background reading:

RELATED REPORTS

2 Minute Medicine Rewind October 19, 2026

Deep learning model demonstrates potential to generate an interpretable brain health biomarker from sleep electroencephalography

1. Haddad F, Hunt SA, Rosenthal DN, Murphy DJ. Right ventricular function in cardiovascular disease, parts I and II: anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation. 2008;117:1436–1448, 1717-1731

 2. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, Greenland P, Jacob DR Jr, Kronmal R, Liu K, Nelson JC, O’Leary D, Saad MF, Shea S, Szklo M, Tracy RP. Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol. 2002;156:871– 881.

This [prospective cohort] study: In this week’s Circulation, Kawut et al report an analysis of cardiac MRIs and subsequent outcomes in >4000 participants of the Multi-Ethnic Study of Atherosclerosis (MESA): a large prospective study designed to assess risk factors and progression of cardiovascular disease in a sample of healthy patients.  The individuals studied were, on average, mildly overweight, normotensive adults in their early 60’s per baseline data.   Median follow-up time was 5.8 years.

After controlling for demographics, hypertension, smoking status, BMI, and CRP levels, the investigators found that the presence of RV hypertrophy doubled the risk of heart failure and cardiovascular death (hazard ratio, 2.52; p<0.001).  This association held even after accounting for the interaction between RV hypertrophy and LV mass  but was stronger for those patients with lower LV mass. 65% of the study sample had pulmonary function testing approximately two years after baseline.  RV hypertrophy remained significantly associated with heart failure and cardiovascular death even after additionally adjusting for pulmonary disease.

In sum: The presence of RV hypertrophy, as measured by cardiac MRI in patients who were clinically disease-free at baseline, was significantly associated with an increased risk of heart failure or cardiovascular death, even after accounting for LV mass.

Although it is possible that RV hypertrophy may directly contribute to heart failure, the correlation seen in this study does not prove causality.  One very plausible explanation is that RV hypertrophy might be speaking for unmeasured variables that increase both RV afterload and the risk of cardiovascular events; examples include sleep breathing disorders and subclinical pulmonary disease.  Another possibility is that RV hypertrophy might herald an increased risk of heart failure by serving as a very sensitive gauge for LV dysfunction. 

Overall, these provocative results, linking RV structure to cardiovascular disease in community-based patients, serve as a call for further study of possible mechanisms and therapies.

Click to read the study in Circulation 

 Click to read an accompanying editorial in Circulation

  By MP and MS

  © 2012 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. DISCALIMER: Posts are not medical advice and are not intended as such. Please see a healthcare professional if you seek medical advice.

Previous Post

Vitamin D supplementation does not decrease incidence of viral upper respiratory tract infections

Next Post

Health care utilization is higher among patients undergoing liver transplantation for nonalcoholic steatohepatitis (NASH)

RelatedReports

A graphic featuring a heart, kidney, bladder, stethoscope, and an ultrasound machine, arranged in a flower-like design on a light blue background.
Weekly Rewinds

2 Minute Medicine Rewind October 19, 2026

October 19, 2026
A sleeping child with electrodes on the scalp, surrounded by a moon and night sky, illustrating sleep monitoring and brain health assessment.
Artificial Intelligence

Deep learning model demonstrates potential to generate an interpretable brain health biomarker from sleep electroencephalography

October 19, 2026
A surgical tray with instruments, balanced scales indicating cost, and monetary coins, symbolizing the economics of surgery and complication management.
Gastroenterology

Low-pressure pneumoperitoneum does not reduce pain after laporoscopic cholecystectomy

October 19, 2026
Depiction of a brain with highlighted areas of activity next to a hand reaching towards a pain signal, alongside an MRI machine, suggesting investigation of pain perception mechanisms.
Chronic Disease

A reduced length protocol for peripheral magnetic stimulation may be as effective compared to standard length protocol for upper trapezius myofascial pain syndrome

October 18, 2026
Next Post

Health care utilization is higher among patients undergoing liver transplantation for nonalcoholic steatohepatitis (NASH)

Postoperative COX-2 Selective NSAIDs associated with anastomotic leakage following colorectal resection

Beta-blockers are not associated with lower risk of myocardial infarction (MI) or stroke in stable outpatients

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • 2 Minute Medicine Rewind October 19, 2026
  • Deep learning model demonstrates potential to generate an interpretable brain health biomarker from sleep electroencephalography
  • Low-pressure pneumoperitoneum does not reduce pain after laporoscopic cholecystectomy
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.